ACE2 trials suggest remodeling, not dilation, as primary therapeutic effect
Pulm Circ
.
2022 Jan 20;12(1):e12022.
doi: 10.1002/pul2.12022.
eCollection 2022 Jan.
Author
James West
1
Affiliation
1
Vanderbilt University Nashville Tennessee USA.
PMID:
35506063
PMCID:
PMC9053010
DOI:
10.1002/pul2.12022
No abstract available
Publication types
Editorial
Grants and funding
R01 HL095797/HL/NHLBI NIH HHS/United States